NCT02819661

Brief Summary

The study will examine whether there is a difference in the frequencies of respiratory depression among obese women receiving spinal anesthesia combined with opioids compared to women with normal BMI. If such a risk exists further investigation will be required to establish the proper criteria for the administration of morphine with spinal anesthesia to obese women.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 15, 2016

Completed
15 days until next milestone

First Posted

Study publicly available on registry

June 30, 2016

Completed
1.8 years until next milestone

Study Start

First participant enrolled

May 1, 2018

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2019

Completed
Last Updated

May 30, 2018

Status Verified

May 1, 2018

Enrollment Period

1.2 years

First QC Date

June 15, 2016

Last Update Submit

May 27, 2018

Conditions

Keywords

Elective Caesarean Sectionobese womenBMI≥30spinal anesthesia combined with intrathecal morphine

Outcome Measures

Primary Outcomes (1)

  • Evidence of clinical respiratory depression by SOMNOtouchTM device monitoring

    one year

Study Arms (4)

women BMI<30 POD 1

ACTIVE COMPARATOR

Pregnant healthy women with BMI\<30 receiving spinal anesthesia with intrathecal morphine during elective caesarean section will be monitored by SOMNOTOUCH RESP post operative day 1 after elective cesarean section.

Device: SOMNOTOUCH RESPProcedure: Caesarean sectionDrug: Spinal anesthesia with intrathecal morphine

women BMI≥30 POD 1

ACTIVE COMPARATOR

Pregnant healthy women with BMI≥30 receiving spinal anesthesia with intrathecal morphine during elective caesarean section will be monitored by SOMNOTOUCH RESP post operative day 1 after elective cesarean section.

Device: SOMNOTOUCH RESPProcedure: Caesarean sectionDrug: Spinal anesthesia with intrathecal morphine

women BMI<30 POD4

ACTIVE COMPARATOR

Pregnant healthy women with BMI\<30 receiving spinal anesthesia with intrathecal morphine during elective caesarean section will be monitored by SOMNOTOUCH RESP post operative day 4 after elective cesarean section.

Device: SOMNOTOUCH RESPProcedure: Caesarean sectionDrug: Spinal anesthesia with intrathecal morphine

women BMI≥30 POD 4

ACTIVE COMPARATOR

Pregnant healthy women with BMI≥30 receiving spinal anesthesia with intrathecal morphine during elective caesarean section will be monitored by SOMNOTOUCH RESP post operative day 4 after elective cesarean section.

Device: SOMNOTOUCH RESPProcedure: Caesarean sectionDrug: Spinal anesthesia with intrathecal morphine

Interventions

Ventilatory effort recorder

women BMI<30 POD 1women BMI<30 POD4women BMI≥30 POD 1women BMI≥30 POD 4

Cesarean delivery is defined as the delivery of a fetus through surgical incisions made through the abdominal wall (laparotomy) and the uterine wall (hysterotomy).

women BMI<30 POD 1women BMI<30 POD4women BMI≥30 POD 1women BMI≥30 POD 4

is a form of regional anaesthesia involving injection of a local anaesthetic into the subarachnoid space

Also known as: Subarachnoid block with intrathecal morphine, spinal block with intrathecal morphine
women BMI<30 POD 1women BMI<30 POD4women BMI≥30 POD 1women BMI≥30 POD 4

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Pregnancy
  • Healthy women

You may not qualify if:

  • Heart diseases
  • Autoimmune diseases
  • Respiratory diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rambam healthcare campus

Haifa, Isreal, Israel

RECRUITING

MeSH Terms

Conditions

Respiratory Insufficiency

Interventions

Cesarean SectionAnesthesia, Spinal

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Delivery, ObstetricObstetric Surgical ProceduresSurgical Procedures, OperativeAnesthesia, ConductionAnesthesiaAnesthesia and Analgesia

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 15, 2016

First Posted

June 30, 2016

Study Start

May 1, 2018

Primary Completion

June 30, 2019

Study Completion

June 30, 2019

Last Updated

May 30, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share

Locations